ImmuPharma plc (LON:IMM – Get Free Report) shares shot up 16.8% during mid-day trading on Friday . The company traded as high as GBX 4.79 ($0.06) and last traded at GBX 4.56 ($0.06). 5,517,724 shares were traded during trading, a decline of 74% from the average session volume of 21,310,188 shares. The stock had previously closed at GBX 3.90 ($0.05).
ImmuPharma Price Performance
The company has a fifty day moving average price of GBX 2.39 and a 200 day moving average price of GBX 1.93. The company has a market cap of £20.32 million, a PE ratio of -488.00 and a beta of 1.53.
ImmuPharma Company Profile
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Further Reading
- Five stocks we like better than ImmuPharma
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- How to Capture the Benefits of Dividend Increases
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- Where Do I Find 52-Week Highs and Lows?
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
